Overview

The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction

Status:
Not yet recruiting

Trial end date:
2026-06-01

Target enrollment:

Participant gender:

Summary

The primary objective of the PERI-STEMI trial is to assess whether sacubitril-valsartan is more effective in preventing adverse LV remodeling for patients with ST-elevation myocardial infarction (STEMI) than enalapril.

Phase:

Phase 3

Details

Lead Sponsor:

West China Hospital

Treatments:

Enalapril
LCZ 696
Sacubitril and valsartan sodium hydrate drug combination
Valsartan